Table 2.

Comparison of the cumulative days of each symptom during the intake period.

Symptoms	Group	1–4 W			1–8 W			1–12 W
		Without	With	p-value	Without	With	p-value	Without	With	p-value
Runny nose	Placebo	2,187	417	0.026*	4,277	931	0.419	6,482	1,330	0.248
	LG2055	2,172	488		4,336	984		6,565	1,415
Nasal congestion	Placebo	2,277	327	0.006*	4,517	691	0.004*	6,756	1,056	<0.001*
	LG2055	2,390	270		4,714	606		7,066	914
Sneezing	Placebo	2,392	212	0.256	4,579	629	<0.001*	6,789	1,023	<0.001*
	LG2055	2,466	194		4,797	523		7,128	852
Sore throat	Placebo	2,323	281	0.258	4,667	541	0.848	7,056	756	0.471
	LG2055	2,346	314		4,774	546		7,180	800
Hoarseness	Placebo	2,431	173	<0.001*	4,857	351	<0.001*	7,303	509	<0.001*
	LG2055	2,576	84		5,120	200		7,669	311
Cough	Placebo	2,383	221	<0.001*	4,788	420	<0.001*	7,174	638	<0.001*
	LG2055	2,511	149		5,038	282		7,566	414
Headache	Placebo	2,423	181	<0.001*	4,847	361	<0.001*	7,283	529	<0.001*
	LG2055	2,534	126		5,100	220		7,674	306
General malaise	Placebo	2,421	183	0.036*	4,826	382	0.004*	7,266	546	<0.001*
	LG2055	2,511	149		5,004	316		7,544	436
Chills	Placebo	2,504	100	0.066	4,997	211	<0.001*	7,546	266	<0.001*
	LG2055	2,583	77		5,178	142		7,795	185
Feverishness	Placebo	2,544	60	<0.001*	5,075	133	<0.001*	7,628	184	<0.001*
	LG2055	2,631	29		5,251	69		7,875	105
Fatigue	Placebo	2,328	276	0.253	4,695	513	0.447	7,065	747	0.428
	LG2055	2,404	256		4,820	500		7,247	733
Feeling unwell	Placebo	2,511	93	0.019*	5,016	192	<0.001*	7,555	257	0.036*
	LG2055	2,595	65		5,186	134		7,763	217

^*Significant difference between the two groups (p < 0.05).